                         SEQUENCE LISTING

<110>  Sanford Burnham Prebys Medical Discovery Institute
       Pasquale, Elena B.
       Dawson, Philip
       Riedl , Stefan  J.
 
<120>  Cyclic EphA4 Antagonists for Neuroprotection and Neural Repair

<130>  13-031-03PCT/3IPSB2.0001WO

<150>  62/025,002
<151>  2014-07-15

<160>  124   

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor pepide antagonist

<400>  1

Lys Tyr Leu Pro Tyr Trp Pro Val Leu Ser Ser Leu 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  2

Ala Pro Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Seqeunce

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly, Gln, Asp, Leu, Ser, Phe, or Tyr

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is Pro or Ala

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Tyr, Phe, Trp, Val, Leu, His or Ile

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is Val or Leu

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid

<400>  3

Xaa Xaa Xaa Cys Xaa Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  4
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is Pro or Ala

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is Tyr, Phe, Trp, Val, Leu, His or Ile

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X is Val or Leu

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid

<400>  4

Xaa Xaa Cys Xaa Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is Tyr, Phe, Trp, Val, Leu, His or Ile

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Val or Leu

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid

<400>  5

Xaa Cys Xaa Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly or Gln

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is Val or Leu

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid except Pro

<400>  6

Xaa Pro Xaa Cys Xaa Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X is Val or Leu

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid except Pro

<400>  7

Pro Xaa Cys Xaa Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Val or Leu

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<400>  8

Xaa Cys Xaa Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly or Gln

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is Pro or Ala

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid except Pro

<400>  9

Xaa Xaa Xaa Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  10
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is Pro or Ala

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid except Pro

<400>  10

Xaa Xaa Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<400>  11

Xaa Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  12
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly or Gln

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid except Pro

<400>  12

Xaa Pro Xaa Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  13
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid except Pro

<400>  13

Pro Xaa Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<400>  14

Xaa Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  15
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly or Gln

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid except Pro

<400>  15

Xaa Pro Tyr Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  16
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid except Pro

<400>  16

Pro Tyr Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X is Tyr, Phe, Trp or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<400>  17

Tyr Cys Val Xaa Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  18
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly or Gln

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid except Pro

<400>  18

Xaa Pro Xaa Cys Val Tyr Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  19
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid except Pro

<400>  19

Pro Xaa Cys Val Tyr Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is Tyr, Phe, Trp, Val, Leu or His

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<400>  20

Xaa Cys Val Tyr Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  21
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly or Gln

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid except Pro

<400>  21

Xaa Pro Tyr Cys Val Tyr Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  22
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid except Pro

<400>  22

Pro Tyr Cys Val Tyr Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  23
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid except Pro

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<400>  23

Tyr Cys Val Tyr Xaa Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  24
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor cyclic peptide 
       antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla, DAla, Ala, Glu, Gly or Gln

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid except Pro

<400>  24

Xaa Pro Tyr Cys Val Tyr Arg Xaa Xaa Trp Xaa Cys 
1               5                   10          


<210>  25
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid except Pro

<400>  25

Pro Tyr Cys Val Tyr Arg Xaa Xaa Trp Xaa Cys 
1               5                   10      


<210>  26
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence for EphA4 receptor antagonist cyclic 
       peptide


<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid except Pro

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid except Pro

<400>  26

Tyr Cys Val Tyr Arg Xaa Xaa Trp Xaa Cys 
1               5                   10  


<210>  27
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  27

Ala Pro Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  28
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  28

Pro Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10      


<210>  29
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is DAla

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  29

Xaa Pro Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  30
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  30

Xaa Pro Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  31
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  31

Ala Pro Tyr Cys Val Tyr Arg Ala Ser Trp Ser Cys 
1               5                   10          


<210>  32
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is Aib

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  32

Ala Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  33
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is DAla

<400>  33

Ala Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  34
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is D-Ala

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  34

Ala Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  35
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  35

Ala Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  36
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  36

Ala Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  37
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  37

Ala Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  38
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is bALA

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  38

Ala Leu Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  39
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  39

Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  40
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  40

Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  41
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  41

Lys Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  42
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  42

Lys Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  43
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  43

His Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  44
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  AMIDATION

<400>  44

Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10  


<210>  45
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is bAla

<400>  45

Ala Pro Tyr Cys Val Tyr Lys Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  46
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  46

Xaa Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  47
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  47

Xaa Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  48
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is bAla

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X is bAla

<400>  48

Xaa Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  49
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  49

Xaa Pro Tyr Cys Val Tyr Arg Xaa Glu Trp Glu Cys 
1               5                   10          


<210>  50
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  50

Xaa Pro Tyr Cys Val Tyr Arg Xaa Glu Trp Glu Cys 
1               5                   10          


<210>  51
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is D-Ala

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  51

Xaa Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  52
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is D-Ala

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  AMIDATION

<400>  52

Xaa Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  53
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  53

Ala Pro Tyr Cys Val Trp Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  54
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  54

Ala Pro Tyr Cys Val Tyr Thr Xaa Glu Trp Leu Cys 
1               5                   10          


<210>  55
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  55

Ala Pro Tyr Cys Val Tyr Asn Xaa Thr Trp Asn Cys 
1               5                   10          


<210>  56
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  56

Ala Pro Tyr Cys Val Tyr Arg Xaa Val Trp Glu Cys 
1               5                   10          


<210>  57
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  57

Ala Pro Val Cys Val Trp Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  58
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  58

Ala Pro Leu Cys Val Trp Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  59
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  59

Ala Pro Leu Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  60
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  60

Ala Pro Trp Cys Val Phe Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  61
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  61

Ala Pro His Cys Val Phe Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  62
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  62

Ala Pro Phe Cys Leu Tyr Thr Xaa Asp Trp Val Cys 
1               5                   10          


<210>  63
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  63

Ala Pro Tyr Cys Val Tyr Asp Xaa Thr Trp Ile Cys 
1               5                   10          


<210>  64
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  64

Ala Pro Tyr Cys Val Tyr Ser Xaa Thr Trp His Cys 
1               5                   10          


<210>  65
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  65

Ala Pro Tyr Cys Val Tyr Asp Xaa Ser Trp Asn Cys 
1               5                   10          


<210>  66
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  66

Ala Pro Tyr Cys Val Tyr Gln Xaa Tyr Trp Lys Cys 
1               5                   10          


<210>  67
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  67

Ala Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  68
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  68

Glu Pro Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  69
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  X is bAla

<400>  69

Ala Pro Leu Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10          


<210>  70
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  70

Ala Pro Tyr Cys Val Trp Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  71
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  71

Ala Pro Val Cys Val Trp Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  72
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  72

Ala Pro Leu Cys Val Trp Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  73
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  73

Ala Pro Leu Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  74
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  74

Ala Pro Ile Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  75
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  75

Ala Pro Trp Cys Val Phe Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  76
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  76

Ala Pro His Cys Val Phe Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  77
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  77

Ala Pro Tyr Cys Ser Tyr Tyr Gly Gln Trp Met Cys 
1               5                   10          


<210>  78
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  78

Ala Pro Phe Cys Leu Tyr Thr Gly Asp Trp Val Cys 
1               5                   10          


<210>  79
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  79

Ala Pro Phe Cys Ser Trp Ala Gly Trp Trp Thr Cys 
1               5                   10          


<210>  80
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  80

Ala Pro Tyr Cys Val Tyr Thr Gly Glu Trp Leu Cys 
1               5                   10          


<210>  81
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  81

Ala Pro Tyr Cys Val Tyr Asp Gly Thr Trp Ile Cys 
1               5                   10          


<210>  82
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  82

Ala Pro Tyr Cys Val Tyr Gly Gly Thr Trp Arg Cys 
1               5                   10          


<210>  83
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  83

Ala Pro Tyr Cys Val Tyr Ser Gly Thr Trp His Cys 
1               5                   10          


<210>  84
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  84

Ala Pro Tyr Cys Val Tyr Asn Gly Thr Trp Asn Cys 
1               5                   10          


<210>  85
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  85

Ala Pro Tyr Cys Val Tyr Asp Gly Ser Trp Asn Cys 
1               5                   10          


<210>  86
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  86

Ala Pro Tyr Cys Val Tyr Lys Gly Ser Trp Asn Cys 
1               5                   10          


<210>  87
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  87

Ala Pro Tyr Cys Val Tyr Glu Gly Leu Trp Asn Cys 
1               5                   10          


<210>  88
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  88

Ala Pro Tyr Cys Val Tyr Ser Gly Val Trp Asn Cys 
1               5                   10          


<210>  89
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  89

Ala Pro Tyr Cys Val Tyr Ser Gly Trp Trp Lys Cys 
1               5                   10          


<210>  90
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  90

Ala Pro Tyr Cys Val Tyr Ser Gly Arg Trp Glu Cys 
1               5                   10          


<210>  91
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  91

Ala Pro Tyr Cys Val Tyr Arg Gly Val Trp Glu Cys 
1               5                   10          


<210>  92
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  92

Ala Pro Tyr Cys Val Tyr Gln Gly Leu Trp Glu Cys 
1               5                   10          


<210>  93
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  93

Ala Pro Tyr Cys Val Tyr Gly Gly Leu Trp Thr Cys 
1               5                   10          


<210>  94
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  94

Ala Pro Tyr Cys Val Tyr Ala Gly Lys Trp Ser Cys 
1               5                   10          


<210>  95
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  95

Ala Pro Tyr Cys Val Tyr Gln Gly Tyr Trp Lys Cys 
1               5                   10          


<210>  96
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  96

Ala Pro Tyr Cys Val Tyr Asn Gly Arg Trp Asp Cys 
1               5                   10          


<210>  97
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  97

Ala Pro Tyr Cys Val Tyr Arg Gly His Trp Gly Cys 
1               5                   10          


<210>  98
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  98

Gly Pro Tyr Cys Val Tyr Lys Gly Asn Trp Trp Cys 
1               5                   10          


<210>  99
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  99

Ala Pro Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  100
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  100

Glu Pro Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  101
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  101

Asp Ala Tyr Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  102
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  102

Ala Ala Phe Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  103
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  103

Ala Pro Leu Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  104
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  104

Leu Pro Leu Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  105
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  105

Gly Pro Leu Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  106
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  106

Ser Ala Leu Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  107
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  107

Gln Ala Leu Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  108
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  108

Phe Pro Val Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  109
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  109

Leu Pro Val Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  110
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist

<400>  110

Tyr Pro Met Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  111
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Library 1 amino acid sequence for phage display screen


<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is any amino acid

<400>  111

Ala Pro Xaa Cys Val Xaa Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  112
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Library 2 amino acid sequence for phage display screen


<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is Tyr ot Phe

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X is Tyr, Phe, Trp, Leu or Cys

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid

<400>  112

Ala Pro Xaa Cys Xaa Xaa Xaa Gly Xaa Xaa Xaa Cys 
1               5                   10          


<210>  113
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Library 3 amino acid sequence for phage display screen


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X is any amino acid

<400>  113

Ala Pro Tyr Cys Val Tyr Xaa Gly Xaa Trp Xaa Cys 
1               5                   10          


<210>  114
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Library 4 amino acid sequence for phage display screen


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X is any amino acid

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  X is any amino acid

<400>  114

Xaa Xaa Xaa Cys Val Tyr Arg Gly Ser Trp Ser Cys 
1               5                   10          


<210>  115
<211>  85
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Library 1 oligonucliotide primer sequence for phage display 
       screen


<220>
<221>  misc_feature
<222>  (43)..(44)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (52)..(53)
<223>  n is a, c, g, or t

<400>  115
catgtttcgg ccgatcctcc tccacacgac caagaacccc tmnncacaca mnncggagca       60

gagtgagaat agaaaggtac ccggg                                             85


<210>  116
<211>  85
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Library 2 oligonucliotide primer sequence for phage display 
       screen


<220>
<221>  misc_feature
<222>  (28)..(29)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (31)..(32)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (34)..(35)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (40)..(41)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (46)..(47)
<223>  n is a, c, g, or t

<400>  116
catgtttcgg ccgatcctcc tccacamnnm nnmnnaccmn nmhamnnaca awacggagca       60

gagtgagaat agaaaggtac ccggg                                             85


<210>  117
<211>  85
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Library 3 oligonucliotide primer sequence for phage display 
       screen


<220>
<221>  misc_feature
<222>  (28)..(29)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (34)..(35)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (40)..(41)
<223>  n is a, c, g, or t

<400>  117
catgtttcgg ccgatcctcc tccacamnnc camnnaccmn natacacaca atacggagca       60

gagtgagaat agaaaggtac ccggg                                             85


<210>  118
<211>  85
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Library 4 oligonucliotide primer sequence for phage display 
       screen


<220>
<221>  misc_feature
<222>  (52)..(53)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (55)..(56)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (58)..(59)
<223>  n is a, c, g, or t

<400>  118
catgtttcgg ccgatcctcc tccacacgac caagaacccc tatacacaca mnnmnnmnna       60

gagtgagaat agaaaggtac ccggg                                             85


<210>  119
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is Ahx

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  119

Xaa Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  120
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is Ava

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  120

Xaa Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  121
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is gammaAbu

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  121

Xaa Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  122
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  122

Xaa Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  123
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  123

Gly Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


<210>  124
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EphA4 receptor cyclic peptide antagonist


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is Sar

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  X is bAla

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  AMIDATION

<400>  124

Xaa Tyr Cys Val Tyr Arg Xaa Ser Trp Ser Cys 
1               5                   10      


